Intense biogeochemical iron cycling revealed in Neoarchean micropyrites from stromatolites

International audienceIron isotope compositions of sedimentary pyrites (FeS2) are used to constrain the redox evolution of the Precambrian ocean and early Fe-based metabolisms such as Dissimilatory Iron Reduction (DIR). Sedimentary pyrites can record biotic and abiotic iron reduction, which have similar ranges of Fe isotopic fractionation, as well as post-depositional histories and metamorphic overprints that can modify Fe isotope compositions. However, some exceptionally well-preserved sedimentary records, such as the stromatolite-bearing Tumbiana Formation (ca. 2.7 Ga, Western Australia) have been proven to retain primary information on Early Neoarchean microbial ecosystems and associated metabolic pathways. Here, we present in situ Fe isotope measurements of micropyrites included in four stromatolites from the Tumbiana Formation in order to assess iron respiration metabolism using Fe isotope signatures. A set of 142 micropyrites has been analyzed in three lamina types, i.e. micritic, organic-rich and fenestral laminae, by Secondary Ion Mass Spectrometry (SIMS), using a Hyperion radio-frequency plasma source. The diversity of laminae is attributed to specific depositional environments, leading to the formation of Type 1 (micritic laminae) and Type 2 (organic-rich laminae) and early diagenetic effects (Type 3, fenestral laminae). Type 1 and 2 laminae preserved comparable δ56Fe ranges, respectively from −1.76‰ to +4.15‰ and from −1.54‰ to +4.44‰. Type 3 laminae recorded a similar range, although slightly more negative δ56Fe values between −2.20‰ and +2.65‰. Globally, our data show a large range of δ56Fe values, from −2.20‰ to +4.44‰, with a unimodal distribution that differs from the bimodal distribution previously reported in the Tumbiana stromatolites. Such a large range and unimodal distribution cannot be explained by a unique process (e.g., biotic/abiotic Fe reduction or pyrite formation only controlled by the precipitation rate). It rather could reflect a two-step iron cycling process in the sediment pore water including i) partial Fe oxidation forming Fe(OH)3 with positive δ56Fe values followed by ii) partial, possibly microbially induced, Fe reduction leading to Fe2+ availability for pyrite formation by sulfate reducers carrying both negative δ56Fe and δ34S signatures. In this model, the buildup and subsequent reduction through time of a residual Fe(OH)3 reservoir arising from the activity of methanotrophs, can explain the strongly positive δ56FeFe(OH)3 values up to 4‰. These results indicate that Archean microbial mats have been the site of the interaction of several closely linked biogeochemical cycles involving Fe, S and C

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Life-threatening `breakthrough' cases of critical COVID-19 are attributed to poor or waning antibody response to the SARS- CoV-2 vaccine in individuals already at risk. Pre-existing autoantibodies (auto-Abs) neutralizing type I IFNs underlie at least 15% of critical COVID-19 pneumonia cases in unvaccinated individuals; however, their contribution to hypoxemic breakthrough cases in vaccinated people remains unknown. Here, we studied a cohort of 48 individuals ( age 20-86 years) who received 2 doses of an mRNA vaccine and developed a breakthrough infection with hypoxemic COVID-19 pneumonia 2 weeks to 4 months later. Antibody levels to the vaccine, neutralization of the virus, and auto- Abs to type I IFNs were measured in the plasma. Forty-two individuals had no known deficiency of B cell immunity and a normal antibody response to the vaccine. Among them, ten (24%) had auto-Abs neutralizing type I IFNs (aged 43-86 years). Eight of these ten patients had auto-Abs neutralizing both IFN-a2 and IFN-., while two neutralized IFN-omega only. No patient neutralized IFN-ss. Seven neutralized 10 ng/mL of type I IFNs, and three 100 pg/mL only. Seven patients neutralized SARS-CoV-2 D614G and the Delta variant (B.1.617.2) efficiently, while one patient neutralized Delta slightly less efficiently. Two of the three patients neutralizing only 100 pg/mL of type I IFNs neutralized both D61G and Delta less efficiently. Despite two mRNA vaccine inoculations and the presence of circulating antibodies capable of neutralizing SARS-CoV-2, auto-Abs neutralizing type I IFNs may underlie a significant proportion of hypoxemic COVID-19 pneumonia cases, highlighting the importance of this particularly vulnerable population

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

In an international cohort of 279 patients with hypoxemic influenza pneumonia, we identified 13 patients (4.6%) with autoantibodies neutralizing IFN-alpha and/or -omega, which were previously reported to underlie 15% cases of life-threatening COVID-19 pneumonia and one third of severe adverse reactions to live-attenuated yellow fever vaccine. Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-alpha 2 alone (five patients) or with IFN-omega (eight patients) from a cohort of 279 patients (4.7%) aged 6-73 yr with critical influenza pneumonia. Nine and four patients had antibodies neutralizing high and low concentrations, respectively, of IFN-alpha 2, and six and two patients had antibodies neutralizing high and low concentrations, respectively, of IFN-omega. The patients' autoantibodies increased influenza A virus replication in both A549 cells and reconstituted human airway epithelia. The prevalence of these antibodies was significantly higher than that in the general population for patients 70 yr of age (3.1 vs. 4.4%, P = 0.68). The risk of critical influenza was highest in patients with antibodies neutralizing high concentrations of both IFN-alpha 2 and IFN-omega (OR = 11.7, P = 1.3 x 10(-5)), especially those <70 yr old (OR = 139.9, P = 3.1 x 10(-10)). We also identified 10 patients in additional influenza patient cohorts. Autoantibodies neutralizing type I IFNs account for similar to 5% of cases of life-threatening influenza pneumonia in patients <70 yr old

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-alpha 2 in 10 patients: IFN-alpha 2 only in three, IFN-alpha 2 plus IFN-omega in five, and IFN-alpha 2, IFN-omega plus IFN-beta in two; IFN-omega only in nine patients). Seven children (3.8%) had Abs neutralizing at least 10 ng/ml of one IFN, whereas the other 12 (6.6%) had Abs neutralizing only 100 pg/ml. The auto-Abs neutralized both unglycosylated and glycosylated IFNs. We also detected auto-Abs neutralizing 100 pg/ml IFN-alpha 2 in 4 of 2,267 uninfected children (0.2%) and auto-Abs neutralizing IFN-omega in 45 children (2%). The odds ratios (ORs) for life-threatening COVID-19 pneumonia were, therefore, higher for auto-Abs neutralizing IFN-alpha 2 only (OR [95% CI] = 67.6 [5.7-9,196.6]) than for auto-Abs neutralizing IFN-. only (OR [95% CI] = 2.6 [1.2-5.3]). ORs were also higher for auto-Abs neutralizing high concentrations (OR [95% CI] = 12.9 [4.6-35.9]) than for those neutralizing low concentrations (OR [95% CI] = 5.5 [3.1-9.6]) of IFN-omega and/or IFN-alpha 2

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-w (IFN-w) (13 patients), against the 13 types of IFN-a (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro. These auto-Abs were not found in 663 individuals with asymptomatic or mild SARS-CoV-2 infection and were present in only 4 of 1227 healthy individuals. Patients with auto-Abs were aged 25 to 87 years and 95 of the 101 were men. A B cell autoimmune phenocopy of inborn errors of type I IFN immunity accounts for life-threatening COVID-19 pneumonia in at least 2.6% of women and 12.5% of men

Détermination de la structure cristalline du fluorobéryllate de cupritétrammine monohydraté : Cu [(NH3)4] H2O Be F4

Cu[(NH₃)₄ H₂O] BeF₄ crystalizes in the orthorhombic space group Pnma : the unit cell dimensions are : a = 23.942 ; b = 7.030 ; c = 20.979 Å. There are sixteen formulae per unit cell. The structure is built up from copper coordination polyedron and discrete fluoroberyllate tetraedra connected by hydrogen bonds. Copper coordination polyedron is a square based pyramid. The pyramidal based-plan is built by four nitrogen atoms and the water molecule is situed on the axis perpendicular to this plane.Cu[(NH₃)₄ H₂O] BeF₄ cristallise dans le système orthorhombique groupe spatial Pnma ; les paramètres de la maille sont : a = 23,942 ; b = 7,030 ; c = 20,979 Å. Il y a seize motifs par maille. La structure est formée de polyèdres de coordination du cuivre et de tétraèdres BeF₄²⁻ reliés par liaison hydrogène. Le polyèdre de coordination du cuivre est une pyramide à base carrée déformée. Le plan de base de la pyramide est formé par les quatre atomes d'azote et la molécule d'eau se trouve sur l'axe perpendiculaire à ce plan.Tédenac Jean-Claude, Philippot Etienne, Maurin Maurice. Détermination de la structure cristalline du fluorobéryllate de cupritétrammine monohydraté : Cu [(NH3)4] H2O Be F4. In: Bulletin de la Société française de Minéralogie et de Cristallographie, volume 98, 1, 1975. pp. 36-42

Sources of academic self-efficacy-beliefs: the role of the specificity level of autobiographical memories about academic performance

The impact on academic self-efficacy beliefs of the specificity at which memories of past academic performance are processed was investigated. Relying on autobiographical memory (AM) theories, it was predicted that, for past academic failures, which represent a threat to self-efficacy beliefs, specific processing would help in maintaining high selfefficacy beliefs compared to general processing. For past academic successes, no difference was expected between the two levels of specificity. An experimental study with 54 psychology students was conducted and results confirmed the main hypothesis. A mediating effect of emotional state on the influence of the specificity of processing past academic performance on self-efficacy beliefs was expected. This mediation could not be evidenced

Endoscopic neurolysis of the ulnar nerve: retrospective evaluation of the first 60 cases

International audienc